{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "2476696", "DateCompleted": {"Year": "1989", "Month": "10", "Day": "24"}, "DateRevised": {"Year": "2018", "Month": "02", "Day": "16"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0030-2414", "JournalIssue": {"Volume": "46", "Issue": "5", "PubDate": {"Year": "1989"}}, "Title": "Oncology", "ISOAbbreviation": "Oncology"}, "ArticleTitle": "Anticancer potential of Viva-Natural, a dietary seaweed extract, on Lewis lung carcinoma in comparison with chemical immunomodulators and on cyclosporine-accelerated AKR leukemia.", "Pagination": {"StartPage": "343", "EndPage": "348", "MedlinePgn": "343-8"}, "Abstract": {"AbstractText": ["Viva-Natural, extracted from a dietary seaweed, containing a macrophage-activating polysaccharide, has been confirmed to be active against intraperitoneally implanted Lewis lung carcinoma (LLC) and spontaneous AKR T cell leukemia. The antitumor potential against LLC has been evaluated in comparison with standard synthetic immunomodulators such as pyran copolymer (MVE-2), isoprinosine, levamisole, and tilorone while manipulating the immune systems by immunosuppressive agents, cyclophosphamide (CY) and 2-chloroadenosine. The anti-LLC activity of Viva-Natural has been found to be superior to that of isoprinosine but inferior to that of MVE-2. LLC-enhancing effect of CY could be partially reserved by the subsequent administration of Viva-Natural or MVE-2 but not by isoprinosine. 2-Chloroadenosine, a specific macrophage inhibitor, abrogated the anti-LLC activity of Viva-Natural and isoprinosine but not the activity of MVE-2. Levamisole and tilorone showed no anti-LLC activity. Ethanol-precipitable fraction of water-soluble part of Viva-Natural (crude polysaccharide) demonstrated curative activity similar to that of MVE-2. Viva-Natural reversed the potentiation effect of ciclosporin on the development of leukemia in AKR mice at preleukemic stage."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, School of Medicine, University of Hawaii, Honolulu."}], "LastName": "Furusawa", "ForeName": "E", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Furusawa", "ForeName": "S", "Initials": "S"}], "GrantList": [{"GrantID": "CA 12733", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, P.H.S."]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Oncology", "NlmUniqueID": "0135054", "ISSNLinking": "0030-2414"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Cyclosporins"}, {"RegistryNumber": "0", "NameOfSubstance": "Immunosuppressive Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "8N3DW7272P", "NameOfSubstance": "Cyclophosphamide"}, {"RegistryNumber": "W1SO0V223F", "NameOfSubstance": "Inosine Pranobex"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["immunology", "therapy"], "DescriptorName": "Carcinoma"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Cyclophosphamide"}, {"QualifierName": ["antagonists & inhibitors"], "DescriptorName": "Cyclosporins"}, {"QualifierName": [], "DescriptorName": "Eukaryota"}, {"QualifierName": [], "DescriptorName": "Immunosuppressive Agents"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Inosine Pranobex"}, {"QualifierName": ["immunology", "therapy"], "DescriptorName": "Leukemia, Experimental"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Neoplasm Transplantation"}, {"QualifierName": ["immunology", "therapy"], "DescriptorName": "Neoplasms, Experimental"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1989", "Month": "1", "Day": "1"}, {"Year": "1989", "Month": "1", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1989", "Month": "1", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["2476696", "10.1159/000226746"]}}]}